CTT Pharmaceutical's market value is the price at which a share of CTT Pharmaceutical trades on a public exchange. It measures the collective expectations of CTT Pharmaceutical Holdings investors about its performance. CTT Pharmaceutical is trading at 0.09 as of the 10th of February 2026. This is a 2.74 percent increase since the beginning of the trading day. The stock's open price was 0.0876. With this module, you can estimate the performance of a buy and hold strategy of CTT Pharmaceutical Holdings and determine expected loss or profit from investing in CTT Pharmaceutical over a given investment horizon. Check out CTT Pharmaceutical Correlation, CTT Pharmaceutical Volatility and CTT Pharmaceutical Performance module to complement your research on CTT Pharmaceutical.
It's important to distinguish between CTT Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CTT Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CTT Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
CTT Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CTT Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CTT Pharmaceutical.
0.00
11/12/2025
No Change 0.00
0.0
In 3 months and 1 day
02/10/2026
0.00
If you would invest 0.00 in CTT Pharmaceutical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding CTT Pharmaceutical Holdings or generate 0.0% return on investment in CTT Pharmaceutical over 90 days. CTT Pharmaceutical is related to or competes with Procyon. CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treat... More
CTT Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CTT Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CTT Pharmaceutical Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CTT Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CTT Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use CTT Pharmaceutical historical prices to predict the future CTT Pharmaceutical's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CTT Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CTT Pharmaceutical is out of control given 3 months investment horizon. CTT Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of volatility over the last 3 months. We were able to interpolate and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.49% are justified by taking the suggested risk. Use CTT Pharmaceutical mean deviation of 7.65, and Risk Adjusted Performance of 0.1077 to evaluate company specific risk that cannot be diversified away. CTT Pharmaceutical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.47, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CTT Pharmaceutical will likely underperform. Use CTT Pharmaceutical value at risk, as well as the relationship between the skewness and day typical price , to analyze future returns on CTT Pharmaceutical.
Auto-correlation
-0.17
Insignificant reverse predictability
CTT Pharmaceutical Holdings has insignificant reverse predictability. Overlapping area represents the amount of predictability between CTT Pharmaceutical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CTT Pharmaceutical price movement. The serial correlation of -0.17 indicates that over 17.0% of current CTT Pharmaceutical price fluctuation can be explain by its past prices.
CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.